MerckAnnouncesFirstPatientDosedinPhase3StudyforInvestigationalAntibody-DrugConjugateinColorectalCancer
===2026/5/22 9:21:42===
Contacts
Sebastian Roos
sebastian.roos@merckgroup.com
Phone: +49 151 14 54 1721
=*=*=*=*=*=
当前为第10/10页
上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页